Oncogenic Ras Represses Transforming Growth Factor-β/Smad Signaling by Degrading Tumor Suppressor Smad4

Debabrata Saha, Pran K. Datta, R. Daniel Beauchamp

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

The loss of growth-inhibitory responses to transforming growth factor-β (TGF-β) is a frequent consequence of malignant transformation. Smad2, Smad3, and Smad4 proteins are important mediators of the antiproliferative responses to TGF-β and may become inactivated in some human cancers. Epithelial cells harboring oncogenic Ras mutations often exhibit a loss of TGF-β anti-proliferative responses. To further investigate the effect of oncogenic Ras in TGF-β signaling, we used an isopropyl-1-thio-β-D-galactopyranoside-inducible expression system to express Ha-RasVal-12 in intestinal epithelial cells. Induction of Ha-RasVal-12 caused a decrease in the level of Smad4 expression, inhibited TGF-β-induced complex formation between Smad2/Smad3 and Smad4, blocked Smad4 nuclear translocation, inhibited the TGF-β-mediated decrease in [3H]thymidine incorporation, and repressed TGF-β-activated transcriptional responses. The withdrawal of isopropyl-1-thio-β -D-galactopyranoside or the addition of an inhibitor of the ubiquitin-proteasome pathway restored the Smad4 level and TGF-β-induced Smad complex formation. Forced expression of Smad4 resulted in partial recovery of the TGF-β-mediated growth inhibition and transcriptional responses in the presence of oncogenic Ras. Further, PD98059, a specific inhibitor of the MEK/ERK/mitogen-activated protein kinase pathway prevented the Ras-induced decrease in Smad4 expression and complex formation. Our results suggest a novel mechanism by which oncogenic Ras represses TGF-β signaling by mitogen-activated protein kinase-dependent down-regulation of Smad4, thereby subverting the tumor suppressor function of TGF-β.

Original languageEnglish (US)
Pages (from-to)29531-29537
Number of pages7
JournalJournal of Biological Chemistry
Volume276
Issue number31
DOIs
StatePublished - Aug 3 2001

Fingerprint

Transforming Growth Factors
Tumors
Neoplasms
Mitogen-Activated Protein Kinases
Galactose
Smad2 Protein
Smad3 Protein
Smad4 Protein
Epithelial Cells
Proteasome Inhibitors
Mitogen-Activated Protein Kinase Kinases
Proteasome Endopeptidase Complex
Growth
Ubiquitin
Thymidine
Down-Regulation
Recovery
Mutation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Oncogenic Ras Represses Transforming Growth Factor-β/Smad Signaling by Degrading Tumor Suppressor Smad4. / Saha, Debabrata; Datta, Pran K.; Beauchamp, R. Daniel.

In: Journal of Biological Chemistry, Vol. 276, No. 31, 03.08.2001, p. 29531-29537.

Research output: Contribution to journalArticle

@article{7db62196d67347adb51fc9dbc50f5df7,
title = "Oncogenic Ras Represses Transforming Growth Factor-β/Smad Signaling by Degrading Tumor Suppressor Smad4",
abstract = "The loss of growth-inhibitory responses to transforming growth factor-β (TGF-β) is a frequent consequence of malignant transformation. Smad2, Smad3, and Smad4 proteins are important mediators of the antiproliferative responses to TGF-β and may become inactivated in some human cancers. Epithelial cells harboring oncogenic Ras mutations often exhibit a loss of TGF-β anti-proliferative responses. To further investigate the effect of oncogenic Ras in TGF-β signaling, we used an isopropyl-1-thio-β-D-galactopyranoside-inducible expression system to express Ha-RasVal-12 in intestinal epithelial cells. Induction of Ha-RasVal-12 caused a decrease in the level of Smad4 expression, inhibited TGF-β-induced complex formation between Smad2/Smad3 and Smad4, blocked Smad4 nuclear translocation, inhibited the TGF-β-mediated decrease in [3H]thymidine incorporation, and repressed TGF-β-activated transcriptional responses. The withdrawal of isopropyl-1-thio-β -D-galactopyranoside or the addition of an inhibitor of the ubiquitin-proteasome pathway restored the Smad4 level and TGF-β-induced Smad complex formation. Forced expression of Smad4 resulted in partial recovery of the TGF-β-mediated growth inhibition and transcriptional responses in the presence of oncogenic Ras. Further, PD98059, a specific inhibitor of the MEK/ERK/mitogen-activated protein kinase pathway prevented the Ras-induced decrease in Smad4 expression and complex formation. Our results suggest a novel mechanism by which oncogenic Ras represses TGF-β signaling by mitogen-activated protein kinase-dependent down-regulation of Smad4, thereby subverting the tumor suppressor function of TGF-β.",
author = "Debabrata Saha and Datta, {Pran K.} and Beauchamp, {R. Daniel}",
year = "2001",
month = "8",
day = "3",
doi = "10.1074/jbc.M100069200",
language = "English (US)",
volume = "276",
pages = "29531--29537",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "31",

}

TY - JOUR

T1 - Oncogenic Ras Represses Transforming Growth Factor-β/Smad Signaling by Degrading Tumor Suppressor Smad4

AU - Saha, Debabrata

AU - Datta, Pran K.

AU - Beauchamp, R. Daniel

PY - 2001/8/3

Y1 - 2001/8/3

N2 - The loss of growth-inhibitory responses to transforming growth factor-β (TGF-β) is a frequent consequence of malignant transformation. Smad2, Smad3, and Smad4 proteins are important mediators of the antiproliferative responses to TGF-β and may become inactivated in some human cancers. Epithelial cells harboring oncogenic Ras mutations often exhibit a loss of TGF-β anti-proliferative responses. To further investigate the effect of oncogenic Ras in TGF-β signaling, we used an isopropyl-1-thio-β-D-galactopyranoside-inducible expression system to express Ha-RasVal-12 in intestinal epithelial cells. Induction of Ha-RasVal-12 caused a decrease in the level of Smad4 expression, inhibited TGF-β-induced complex formation between Smad2/Smad3 and Smad4, blocked Smad4 nuclear translocation, inhibited the TGF-β-mediated decrease in [3H]thymidine incorporation, and repressed TGF-β-activated transcriptional responses. The withdrawal of isopropyl-1-thio-β -D-galactopyranoside or the addition of an inhibitor of the ubiquitin-proteasome pathway restored the Smad4 level and TGF-β-induced Smad complex formation. Forced expression of Smad4 resulted in partial recovery of the TGF-β-mediated growth inhibition and transcriptional responses in the presence of oncogenic Ras. Further, PD98059, a specific inhibitor of the MEK/ERK/mitogen-activated protein kinase pathway prevented the Ras-induced decrease in Smad4 expression and complex formation. Our results suggest a novel mechanism by which oncogenic Ras represses TGF-β signaling by mitogen-activated protein kinase-dependent down-regulation of Smad4, thereby subverting the tumor suppressor function of TGF-β.

AB - The loss of growth-inhibitory responses to transforming growth factor-β (TGF-β) is a frequent consequence of malignant transformation. Smad2, Smad3, and Smad4 proteins are important mediators of the antiproliferative responses to TGF-β and may become inactivated in some human cancers. Epithelial cells harboring oncogenic Ras mutations often exhibit a loss of TGF-β anti-proliferative responses. To further investigate the effect of oncogenic Ras in TGF-β signaling, we used an isopropyl-1-thio-β-D-galactopyranoside-inducible expression system to express Ha-RasVal-12 in intestinal epithelial cells. Induction of Ha-RasVal-12 caused a decrease in the level of Smad4 expression, inhibited TGF-β-induced complex formation between Smad2/Smad3 and Smad4, blocked Smad4 nuclear translocation, inhibited the TGF-β-mediated decrease in [3H]thymidine incorporation, and repressed TGF-β-activated transcriptional responses. The withdrawal of isopropyl-1-thio-β -D-galactopyranoside or the addition of an inhibitor of the ubiquitin-proteasome pathway restored the Smad4 level and TGF-β-induced Smad complex formation. Forced expression of Smad4 resulted in partial recovery of the TGF-β-mediated growth inhibition and transcriptional responses in the presence of oncogenic Ras. Further, PD98059, a specific inhibitor of the MEK/ERK/mitogen-activated protein kinase pathway prevented the Ras-induced decrease in Smad4 expression and complex formation. Our results suggest a novel mechanism by which oncogenic Ras represses TGF-β signaling by mitogen-activated protein kinase-dependent down-regulation of Smad4, thereby subverting the tumor suppressor function of TGF-β.

UR - http://www.scopus.com/inward/record.url?scp=0035800838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035800838&partnerID=8YFLogxK

U2 - 10.1074/jbc.M100069200

DO - 10.1074/jbc.M100069200

M3 - Article

C2 - 11371552

AN - SCOPUS:0035800838

VL - 276

SP - 29531

EP - 29537

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 31

ER -